WOMEN'S ROGAINE (nda021812)- (5%)

Generic Name	MINOXIDIL	Innovator	KENVUE BRANDS
Dosage	5%
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2019-Apr-20	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2017-Feb-28
GAIN Expiry	None	Drug Complexity	No
Indication	WOMEN'S ROGAINE is indicated for Hair regrowth on the top of the scalp treatment for women.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	2

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
5%	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of WOMEN'S ROGAINE